| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net income | 354,200 | 226,500 | 95,400 | 381,400 |
| Gain on sale of business | 0 | 0 | - | 4,000 |
| Credit loss on note receivable from collaborative partner | - | - | - | 0 |
| Asset impairments | 700 | 600 | - | - |
| Depreciation | 56,500 | 37,400 | 18,400 | 49,900 |
| Amortization of intangible assets | 96,500 | 63,500 | 31,500 | 75,000 |
| Share-based compensation expense | 23,700 | 18,800 | 13,600 | 20,900 |
| Deferred income taxes | -1,000 | 1,600 | 900 | 400 |
| Receivables net | 20,200 | -1,600 | 12,300 | 14,500 |
| Inventories net | 49,400 | 45,600 | 34,900 | 21,600 |
| Other current assets | 1,400 | 21,800 | 7,000 | 4,600 |
| Trade accounts payable | -1,100 | -700 | 9,600 | 15,300 |
| Deferred revenue | -1,100 | 6,400 | 8,800 | -4,300 |
| Accrued expenses | 10,400 | -22,400 | -17,900 | -500 |
| Other net | -3,100 | -1,500 | 400 | -2,100 |
| Net cash flows provided by operating activities | 470,900 | 267,400 | 105,700 | 495,500 |
| Capital expenditures | 43,900 | 29,100 | 14,300 | 49,600 |
| Acquisition of business, net of cash acquired | 76,500 | -4,200 | -4,200 | 984,500 |
| Proceeds from sale of business, net of cash remitted | 0 | 0 | - | 45,100 |
| Purchases of marketable securities | - | - | - | 0 |
| Proceeds from sale of marketable securities | - | - | - | 4,500 |
| Other net | -400 | -400 | -100 | 7,300 |
| Net cash flows used in investing activities | -120,000 | -24,500 | -10,000 | -991,800 |
| Borrowings under revolving credit facilities | 197,000 | 50,000 | - | 279,300 |
| Proceeds from issuance of long-term borrowings | 0 | - | - | 496,700 |
| Payment of long-term borrowings | 100,000 | 100,000 | - | 25,000 |
| Payments under revolving credit facilities | 185,800 | 92,700 | 30,200 | - |
| Debt issuance costs | 0 | - | - | 1,200 |
| Cash dividends paid to shareholders | 159,400 | 105,900 | 52,400 | 153,000 |
| Proceeds from share issuances, net of shares withheld for taxes | - | - | - | 10,500 |
| (payments) proceeds from share issuances, net of shares withheld for taxes | 1,200 | 200 | 500 | - |
| Repurchases of common stock | 175,000 | 100,000 | 50,000 | 0 |
| Other net | -500 | -400 | -200 | -600 |
| Net cash flows (used in) provided by financing activities | -424,900 | -349,200 | -133,300 | 606,700 |
| Effect of exchange rate changes on cash and cash equivalents | 34,800 | 37,400 | 10,900 | 6,600 |
| Net (decrease) increase in cash and cash equivalents and restricted cash | -39,200 | -68,900 | -26,700 | 117,000 |
| Cash and cash equivalents at beginning of period | 638,900 | 638,900 | 638,900 | 534,300 |
| Cash and cash equivalents at end of period | 599,700 | 570,000 | 612,200 | 651,300 |
IDEX CORP DE (IEX)
IDEX CORP DE (IEX)